Dow Down 0.02% Nasdaq Up 0.07%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
2.24 0.00(0.00%) 4:00PM EST
|After Hours : 2.23 Down 0.01 (0.45%) 5:17PM EST
Prev Close:2.24
Open:2.24
Bid:2.17 x 3000
Ask:2.26 x 500
1y Target Est:5.50
Beta:1.64
Next Earnings Date:N/A
Day's Range:2.19 - 2.26
52wk Range:1.69 - 4.25
Volume:761,165
Avg Vol (3m):1,386,280
Market Cap:325.11M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CTIC

Comparison

Symbol% ChgMkt Cap
CTIC 0.00%325.11M
BMYDown 0.59%97.07B
RHHBYDown 0.37%252.84B
SNYUp 0.72%125.04B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.32
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.59
Quarterly EPS Est (Dec-14) :-0.17
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback